Judge Fallon denies new Bellwether trials

Judge Fallon presiding over Xarelto MDL 2592 also denied a motion for new bellwether trials for the plaintiffs who had lost to the defendants in the first two bellwethers trials. The judge stood by his decisions stating that they were made on the right grounds. The plaintiffs had filed the motions highlighting the fact that certain data was deemed inadmissible by the court to be a part of the trials as it included international information. The plaintiffs also emphasized that the jury was informed to consider the drug manufacturers were required to disclose only the FDA approved tests to the patients that clearly excluded the prothrombin time test, which is a part of international labels, but not FDA approved.

We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

MTMP Spring Conference - 2018
Neural IT Team got to pose with Mike Papantonio at the successful book signing event of ‘Law And
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
2nd Quarter 2018 Rewards & Recognition Program Celebrations
2nd Quarter 2018 ‘Rewards & Recognition Program’ Celebrations at NEURAL IT

Latest Tweets